MetaVia, Inc. (MTVA) Total Business Assets

Graphic logo of metaviatx.com (MTVA)

The asset value for MetaVia Inc (MTVA) tracked on this chart is 15.87, illustrating the resources of this biotech firm developing tissue regeneration methods following traumatic brain injuries and strokes. As the company is in the pre-commercial stage, the lack of sales is driving up trial expenses. The core strategy focuses on identifying high-tech methods to combat Alzheimer's disease by correcting interneuronal interactions.

MetaVia (MTVA): Cumulative Company Assets from 11/30/2024 to 10/28/2026

Analytical breakdowns for metaviatx.com (MTVA)

- price and consensus price forecast:
Stock Price MetaVia|MTVA - Price Target Chart
- market capitalization data:
Market Capitalization MetaVia|MTVA - Enterprise Value
- book capitalization data:
Net Asset Value per Share MetaVia|MTVA - Company Net Assets|Market Capitalization to Book Value Ratio metaviatx.com|MTVA - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio MetaVia Inc|MTVA - Long-Term Debt to Equity|Current Liabilities to Capital MetaVia|MTVA - Company Debts|Debt to Book Value MetaVia
Summary company analysis:MetaVia Inc
Finished products of MetaVia Inc

This metric is reverse-calculated via return on assets (ROA), combining equity and liabilities to assess the actual scale of resources at MetaVia Inc (MTVA). The dynamics of consolidated assets reflect the capitalization of patents and molecules within biopharmaceuticals, where asset accumulation serves as the foundation for future monopoly margins, allowing investors to separate market noise from the actual growth of the company's production potential.

Competing companies

BIIB (biogen.com) - Company Total Assets|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|HRMY (Harmony Corp) - Company Assets|Aggregate Company Assets BHVN|Cumulative Company Assets amylyx.com|Trevi Therapeutics, Inc. - Company Total Assets|Company Assets Praxis Precision Medicines Inc PRAX|Cumulative Company Assets Anavex Corp (AVXL)|Aggregate Business Assets CeriBell EEG CBLL|Prothena Corporation plc - Company Total Assets|Alector, Inc. (ALEC) - Company Total Assets|Annexon (ANNX) - Cumulative Company Assets|Omeros (OMER) - Aggregate Company Assets|NGNE: Company Total Assets|Company Total Asset Base AC Immune Inc|Company Total Assets VYGR|Company Total Assets neumoratx.com NMRA|Cumulative Company Assets Scilex|Aggregate Asset Value Tevogen Bio Holdings Inc. TVGN|Company Total Assets ACOG (Alpha Cognition Corp)|CGTX: Company Total Asset Base|Aggregate Company Assets Inhibikase Therapeutics|cassavasciences.com (SAVA) - Total Business Assets|Company Total Assets ASRT|Cumulative Company Assets COYA|Aggregate Company Assets VTGN (Vistagen Therapeutics)|Cumulative Company Assets ovidrx.com OVID|Cumulative Company Assets Acumen Pharmaceuticals (ABOS)|CRVO - Aggregate Business Assets|ATHE - Cumulative Company Assets|CLNN - Aggregate Company Assets|PEPG: Company Total Assets|JUNS (Jupiter Neurosciences, Inc.) - Company Total Assets|Aggregate Company Assets Relmada Therapeutics (RLMD)|Total Business Assets annovisbio.com|Grace Therapeutics, Inc. - Company Total Assets|Company Assets Firefly Neuroscience, Inc. AIFF|Cumulative Company Assets KLTO (Klotho Neurosciences)|NeuroSense Therapeutics Ltd - Company Total Assets|Aggregate Company Assets Reviva Pharmaceuticals (RVPH)|NRXS: Aggregate Asset Value|Aggregate Company Assets HSDT|PASG (Passage Bio) - Company Assets|Aggregate Company Assets NEUP|Cumulative Company Assets Minerva|Athira Pharma, Inc. - Company Total Assets|Company Assets addextherapeutics.com ADXN|Cumulative Company Assets Alzamend Neuro (ALZN)|Aggregate Business Assets Cyclerion Therapeutics Inc. CYCN|Protagenic - Company Total Assets|Pasithea Therapeutics (KTTA) - Company Total Assets|cortigent.com (CRGT) - Cumulative Company Assets|avenuetx.com (ATXI) - Aggregate Company Assets|BCLI: Company Total Assets|Company Total Asset Base Cara Therapeutics Inc.|Company Total Assets CHRO|Company Total Assets eliemtx.com ELYM|Cumulative Company Assets Intra-Cellular Therapies, Inc.|Aggregate Asset Value longboardpharma.com LBPH|Company Total Assets MRNS (Marinus Pharmaceuticals, Inc.)|NKGN: Company Total Asset Base|Aggregate Company Assets NeuroBo|Sage Therapeutics Inc (SAGE) - Total Business Assets|Company Total Assets SNPX|Cumulative Company Assets TRVN|Aggregate Company Assets VIGL (Vigil Neuroscience)|Cumulative Company Assets anewmeds.com WENA|Cumulative Company Assets Cerevel (CERE)